Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer

被引:30
作者
Campani, Virginia [1 ]
Salzano, Giuseppina [2 ]
Lusa, Sara [3 ]
De Rosa, Giuseppe [1 ]
机构
[1] Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy
[2] Univ Paris 11, CNRS, Inst Mol Sci, Univ Paris Saclay, F-91400 Orsay, France
[3] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, I-80138 Naples, Italy
关键词
nucleic acid; cationic liposomes; stable nucleic acid lipid particles (SNALPs); lipid-nanoparticles; micelles; MULTIFUNCTIONAL POLYMERIC MICELLES; MEDIATED DNA TRANSFECTION; OVERCOME DRUG-RESISTANCE; ANTI-SURVIVIN SIRNA; IN-VIVO; CATIONIC LIPIDS; INTRACELLULAR DELIVERY; GENE DELIVERY; ANTISENSE OLIGONUCLEOTIDES; VIRAL VECTORS;
D O I
10.3390/nano6070131
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The growing knowledge on the mechanisms of gene silencing and gene regulation by non-coding RNAs (ncRNA), mainly small interfering RNA (siRNA) and microRNA (miRNA), is providing a significant boost to the development of new therapeutic strategies for the treatment of cancer. However, the design of RNA-based therapeutics is hampered by biopharmaceutical issues, thus requiring the use of suitable delivery strategies. In this regards, lipid nanovectors have been successfully investigated to deliver RNA in different forms of cancer. Compared to other biomaterials, lipids offer advantages such as biocompatibility, biodegradability, easy production, low cost, limited toxicity and immunogenicity. The possibility to formulate these materials in the form of nanovectors allows overcoming biopharmaceutical issues associated to the therapeutic use of RNA, with the possibility to target tumors. This review takes stock of the main lipid nanovectors proposed to deliver ncRNA. For each considered delivery strategy, the rational design and the most meaningful in vitro and in vivo results are reported and discussed.
引用
收藏
页数:22
相关论文
共 102 条
[81]   Progress and problems with the use of viral vectors for gene therapy [J].
Thomas, CE ;
Ehrhardt, A ;
Kay, MA .
NATURE REVIEWS GENETICS, 2003, 4 (05) :346-358
[82]  
Tomanin R, 2004, CURR GENE THER, V4, P357
[83]   Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery [J].
Torchilin, Vladimir P. .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (11) :813-827
[84]   Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules [J].
van de Water, Femke M. ;
Boerman, Otto C. ;
Wouterse, Alfons C. ;
Peters, Janny G. P. ;
Russel, Frans G. M. ;
Masereeuw, Rosalinde .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (08) :1393-1397
[85]   PARAMETERS INFLUENCING THE INTRODUCTION OF PLASMID DNA INTO CELLS BY THE USE OF SYNTHETIC AMPHIPHILES AS A CARRIER SYSTEM [J].
VANDERWOUDE, I ;
VISSER, HW ;
TERBEEST, MBA ;
WAGENAAR, A ;
RUITERS, MHJ ;
ENGBERTS, JBFN ;
HOEKSTRA, D .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1240 (01) :34-40
[86]   Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations [J].
Wang, Xinmei ;
Yu, Bo ;
Ren, Wei ;
Mo, Xiaokui ;
Zhou, Chenguang ;
He, Hongyan ;
Jia, HuLiang ;
Wang, Lu ;
Jacob, Samson T. ;
Lee, Robert J. ;
Ghoshal, Kalpana ;
Lee, L. James .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) :690-698
[87]   Cationic lipids, lipoplexes and intracellular delivery of genes [J].
Wasungu, Luc ;
Hoekstra, Dick .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (02) :255-264
[88]   Nanostructure of cationic lipid-oligonucleotide complexes [J].
Weisman, S ;
Hirsch-Lerner, D ;
Barenholz, Y ;
Talmon, Y .
BIOPHYSICAL JOURNAL, 2004, 87 (01) :609-614
[89]   Knocking down disease: a progress report on siRNA therapeutics [J].
Wittrup, Anders ;
Lieberman, Judy .
NATURE REVIEWS GENETICS, 2015, 16 (09) :543-552
[90]   Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents [J].
Wu, J ;
Lizarzaburu, ME ;
Kurth, MJ ;
Liu, L ;
Wege, H ;
Zern, MA ;
Nantz, MH .
BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :251-257